The fibrin-derived peptide Bβ15-42 significantly attenuates ischemia-reperfusion injury in a cardiac transplant model

Transplantation

Volumn 89, Issue 7, 2010, Pages 824-829

  Wiedemann, Dominik ^a   Schneeberger, Stefan ^a   Friedl, Peter ^b   Zacharowski, Kai ^c   Wick, Nikolaus ^b   Boesch, Florian ^a   Margreiter, Raimund ^a   Laufer, Guenther ^a   Petzelbauer, Peter ^b   Semsroth, Severin ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Fibrin derived peptide B 15 42; Heart transplantation.; Inflammatory response; Ischemia reperfusion; Vascular endothelial cadherin

Indexed keywords

FIBRIN; PROTEIN FX06; TROPONIN T; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CARDIOTONIC AGENT; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN BBETA (15 42); FIBRINOGEN BBETA (15-42); PEPTIDE FRAGMENT; PRESERVATION SOLUTION;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; HEART GRAFT; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART OUTPUT; HEART TRANSPLANTATION; ISOGRAFT; MALE; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; ALLOTRANSPLANTATION; ANIMAL; BLOOD; CELL MOTION; DRUG EFFECT; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART VENTRICLE PRESSURE; LEUKOCYTE; LEWIS RAT; METABOLISM; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; TIME;

ANIMALS; BIOLOGICAL MARKERS; CARDIAC OUTPUT; CARDIOTONIC AGENTS; CELL MOVEMENT; COLD ISCHEMIA; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEART TRANSPLANTATION; LEUKOCYTES; MALE; MODELS, ANIMAL; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NECROSIS; ORGAN PRESERVATION SOLUTIONS; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TROPONIN T; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 77950948801     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ccd822     Document Type: Article

References (26)

1. Jahania MS, Sanchez JA, Narayan P, et al. Heart preservation for transplantation: Principles and strategies. Ann Thorac Surg 1999; 68: 1983.
2. FlissH, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996; 79: 949.
3. Vestweber D. VE-cadherin: The major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008; 28: 223.
4. Dejana E,SpagnuoloR,BazzoniG.Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 2001; 86: 308.
5. Broman MT, Mehta D, Malik AB. Cdc42 regulates the restoration of endothelial adherens junctions and permeability. Trends Cardiovasc Med 2007; 17: 151.
6. Konstantoulaki M, Kouklis P, Malik AB. Protein kinase C modifications of VE-cadherin, p120, and beta-catenin contribute to endothelial barrier dysregulation induced by thrombin. Am J Physiol Lung Cell Mol Physiol 2003; 285: L434.
7. Ukropec JA, Hollinger MK, Salva SM, et al. SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem 2000; 275: 5983.
8. Wojciak-Stothard B,PotempaS,EichholtzT, et al. Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci 2001; 114(pt 7): 1343.
9. Petzelbauer P, Zacharowski PA, Miyazaki Y, et al. The fibrin-derived pep-tide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 2005; 11: 298.
10. Bach TL, Barsigian C, Yaen CH, et al. Endothelial cell VE-cadherin functionsasareceptor for the beta15-42 sequence of fibrin.J Biol Chem 1998; 273: 30719.
11. Fareed J, Hoppensteadt DA, Leya F, et al. Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes. Clin Chem 1998; 44(8 pt 2): 1845.
12. Roesner JP, Petzelbauer P, Koch A, et al. The fibrin-derived peptide Bbeta15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury. Crit Care Med 2007; 35: 1730.
13. Atar D, Petzelbauer P, Schwitter J, et al. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol 2009; 53: 720.
14. Groger M, Pasteiner W, Ignatyev G, et al. Peptide Bbeta(15-42) preserves endothelial barrier function in shock. PLoS One 2009; 4: e5391.
15. Heron I. A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand (A) 1971; 79: 366.
16. Semsroth S, Fellner B, Trescher K, et al. S-nitroso human serum albumin attenuates ischemia/reperfusion injury after cardioplegic arrest in isolated rabbit hearts. J Heart Lung Transplant 2005; 24: 2226.
17. HallstromS, Franz M, Gasser H, et al. S-nitroso human serum albumin reduces ischaemia/reperfusion injury in the pig heart after unprotected warm ischaemia. Cardiovasc Res 2008; 77: 506.
18. Podesser BK, Schirnhofer J, Bernecker OY, et al. Optimizing ischemia/reperfusion in the failing rat heart\Improved myocardial protection with acute ACE inhibition. Circulation 2002; 106(12 suppl 1): I277.
19. Shiraishi Y, Lee JR, Laks H, et al. L-arginine administration during reperfusion improves pulmonary function. Ann Thorac Surg 1996; 62: 1580.
20. Aigner F, Maier HT, Schwelberger HG, et al. Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am J Transplant 2007; 7: 779.
21. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 2004; 61: 481.
22. Ma XL, Weyrich AS, Lefer DJ, et al. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993; 72: 403.
23. Tsao PS, Ma XL, Lefer AM. Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J 1992; 123: 1464.
24. Albertine KH, Weyrich AS, Ma XL, et al. Quantification of neutrophil migration following myocardial ischemia and reperfusion in cats and dogs. J Leukoc Biol 1994; 55: 557.
25. Zhao ZQ, Velez DA, Wang NP, et al. Progressively developed myocar-dial apoptotic cell death during late phase of reperfusion. Apoptosis 2001; 6: 279.
26. Zhao ZQ, Nakamura M, Wang NP, et al. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion. J Surg Res 2000; 94: 133.